My Alzheimer's Journey
Part 148 - Eggs, Subcutaneous Lecanemab Formulation, & Senate Bill 3267
Happy Monday, Everyone.
I have a mixed bag of news to share with you.
Eggs Reduce the Risk of Alzheimer’s
Let’s start with a just released study about eggs and Alzheimer’s disease (AD). May 4, 2026, Loma Linda University Health published an article stating that consumption of eggs is associated with a lower risk of AD. The article summarizes the Adventist Health Study-2 which was conducted by researchers at Loma Linda. The results of the study were published April 17, 2026, in the Journal of Nutrition.
The study included a population of 40,000 United States Seventh-day Adventists. Eligibility was determined using the Medicare Master Beneficiary Summary Files. The average follow-up period was 15.3 years. The study concluded that moderate egg consumption should be part of a balanced diet. Furthermore, moderate consumption of eggs leads to a lower risk of AD.
I am a tad puzzled why this study was conducted since there have been many previous studies that have concluded that moderate egg consumption reduces the risk of AD. For example, the Rancho Bernardo Study in 2024 concluded that, “eggs provide nutrients beneficial for cognitive function.” Also in 2024, the Rush Memory and Aging Project concluded that, “frequent egg consumption is associated with a lower risk of Alzheimer’s dementia and AD pathology”. In 2025, Henry Ford Health called eggs a “brain booster”.
Loma Linda University Health received some funding for their study from the American Egg Board. The Egg Board released a press announcement May 5, 2026, titled, “New and Consistent Data: Including Eggs as Part of a Balanced Diet is Associated with Reduced Risk of Alzheimer’s Disease.” This article is a summary of the Loma Linda study. Is it a conflict of interest smart marketing for the Egg Board to fund a research project that concludes that eating eggs reduces the risk of AD?
FDA Decision Delayed
Biogen and Eisai were expecting a decision from the FDA May 24, 2026, on the use of subcutaneous Lecanemab for treatment initiation. Last Friday, the FDA announced a three-month delay in their decision.
The FDA requested additional information regarding the use of subcutaneous Lecanemab for treatment initiation. The agency then said the information was a “major amendment to the application.” The FDA reviewers now have three additional months to review the data provided by Biogen and Eisai.
In September 2025, the FDA approved a subcutaneous formulation of Lecanemab. This approval, however, only applied to maintenance treatments. New patients would still have to undergo an 18-month period of bi-weekly intravenous infusions.
The new FDA application is to use this subcutaneous formulation to initiate patients, completely eliminating the need for intravenous infusions. If approved, this opens the possibility of at-home, subcutaneous dosing for the entirety of the treatment regimen.
The FDA decision is now expected August 24, 2026.
Important Legislation
Senate Bill 3267, called the “Alzheimer's Screening and Prevention Act” or the “ASAP Act” will provide for Medicare coverage of blood-based Alzheimer’s screening tests.
The House version of the Bill is H.R. 6130.
Please contact your Congressman and Senator and encourage them to vote for passage of this important legislation.
Keeping this light on (and accessible to all)
Writing My Alzheimer’s Journey is one of the most meaningful things I do, but it is also a labor of love that requires significant time, research, and resources.
When I started this blog, I made a conscious choice: I will never put this information behind a paywall. I know firsthand that caregivers are often under immense financial and emotional strain. I want every person—regardless of their bank account balance—to have access to the insights and support shared here.
However, keeping this journey sustainable requires a community effort.
Currently, only a small handful of our 350-strong community are able to donate. If you have found comfort, clarity, or a sense of “I’m not alone” in these words, I’m asking you to consider becoming a partner in this work.
Your donation doesn’t just pay for a website; it ensures that a daughter in over her head or a spouse feeling lost can find the resources they need at 2:00 AM, free of charge.
If you are in a position to help, please consider a donation today.
Thank you for walking this path with me. Your presence here means more than I can say, and your support keeps this light on for everyone.
With gratitude,
Greg
Donations
Go Fund Me (amounts greater than $25)
Buy Big Bit A Treat (small donations)
Amazon Wish List (things that Linda and Greg need)
Shopping
About
Interested In Greg Speaking At Your Event?
Search